A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. : Randomised double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride.

Allegro Inc.0 sites30 target enrollmentMarch 18, 2019

Overview

No summary available.

Registry

who.int

Start Date

March 18, 2019

End Date

April 30, 2019

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Allegro Inc.

•1\) Individuals whose fasting serum triglyceride level is greater than or equal to 150 mg/dL. 2\) A medical history of malignant tumor, heart failure or myocardial infarction. 3\) Currently undergoing treatment for any of the following chronic diseases: atrial fibrillation, cardiac arrhythmia, liver failure, kidney failure, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\) Subjects who currently on medications (including herbal medicines) 5\) Subjects who are allergic to medicines and/or the test food related products. 6\) Subjects with irregular life rhythms such as shift workers, irregular eating habits. 7\) Subjects who are pregnant, breast\-feeding, or planning to get pregnant. 8\) Subjects who have been enrolled in other clinical trials within the last 4 weeks before the agreement to participate in this trial. 9\) Subjects who are considered as ineligible to participate in the study by the physician.